The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’ - Benralizumab is a monoclonal antibody ...

Discover the study that, at week 16, showed how dupilumab demonstrated significant benefits compared to placebo, regardless ...